Estimating the duration of ongoing prevention trials

Area of Science:

• Epidemiology
• Biostatistics
• Clinical Trial Design

Background:

• Estimating the duration of prevention trials is crucial for resource allocation and successful completion.
• Previous methods often underestimated trial duration due to inadequate consideration of population selection factors.
• The Colon Cancer Control Study highlighted the need for improved duration estimation models.

Purpose of the Study:

• To present a novel method for estimating the duration of ongoing prevention trials.
• To adjust for population selection effects in predicting control group event rates and study duration.
• To provide a framework for estimating sample size requirements in certain prevention studies.

Main Methods:

• Developed models using disease-specific and all-cause standardized mortality ratios.
• Incorporated adjustments for various population selection effects.
• Validated the disease-specific mortality ratio model using independent incidence and survival data.

Main Results:

• The proposed method accurately estimates control group event rates and study duration.
• The Colon Cancer Control Study duration was re-estimated using the new method.
• The models effectively account for selection biases impacting event rate predictions.

Conclusions:

• The presented method offers a more reliable approach to estimating prevention trial duration.
• Accurate duration and sample size estimation are vital for the success of large-scale health intervention studies.
• This methodology enhances the planning and execution of future prevention research.